Ftse Mib
34.395,62
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.644,61
0,24%
NASDAQ
18.404,36
-0,37%
Bitcoin
64.493,89
-0,55%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Evgen Pharma Plc (EVG) Evgen Pharma Plc (EVG) Notizie

EVG

Evgen Pharma (EVG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
DataOraFonteTitoloSimboloCompagnia
13/06/202208:00RNS Non-RegulatoryEvgen Pharma PLC Collaboration with University of MichiganLSE:EVGEvgen Pharma Plc
08/06/202215:26Alliance NewsAlliance NewsEvgen Pharma starts trial to test breast cancer tablet; loss narrowsLSE:EVGEvgen Pharma Plc
08/06/202208:01UK RegulatoryEvgen Pharma PLC Full Year ResultsLSE:EVGEvgen Pharma Plc
07/06/202208:01UK RegulatoryEvgen Pharma PLC Notice of ResultsLSE:EVGEvgen Pharma Plc
25/05/202223:02Alliance NewsAlliance NewsTRADING UPDATES: Tekcapital fundraise; Kromek wins US government orderLSE:EVGEvgen Pharma Plc
25/05/202209:31RNS Non-RegulatoryEvgen Pharma PLC Collaboration with Università Sapienza di RomaLSE:EVGEvgen Pharma Plc
29/04/202215:39UK RegulatoryEvgen Pharma PLC Holding(s) in CompanyLSE:EVGEvgen Pharma Plc
15/03/202215:05UK RegulatoryEvgen Pharma PLC Second Price Monitoring ExtnLSE:EVGEvgen Pharma Plc
15/03/202215:00UK RegulatoryEvgen Pharma PLC Price Monitoring ExtensionLSE:EVGEvgen Pharma Plc
07/03/202208:01RNS Non-RegulatoryEvgen Pharma PLC Manchester Breast Centre collaboration expandedLSE:EVGEvgen Pharma Plc
18/01/202212:32Alliance NewsAlliance NewsEvgen signs agreement for Spanish institutions' sulfoaphane analoguesLSE:EVGEvgen Pharma Plc
18/01/202208:00UK RegulatoryEvgen Pharma PLC Option over new sulforaphane analoguesLSE:EVGEvgen Pharma Plc
11/01/202208:00UK RegulatoryEvgen Pharma PLC Progress with UK and US regulators for 2022 trialsLSE:EVGEvgen Pharma Plc
08/12/202115:08UK RegulatoryEvgen Pharma PLC Grant of OptionsLSE:EVGEvgen Pharma Plc
07/12/202122:49Alliance NewsAlliance NewsEARNINGS UPDATES: Carr's beats expectations; Premier assets hit recordLSE:EVGEvgen Pharma Plc
07/12/202107:59UK RegulatoryEvgen Pharma PLC Half-year ReportLSE:EVGEvgen Pharma Plc
10/11/202119:22Alliance NewsAlliance NewsTRADING UPDATES: Permanent TSB sells loan portfolio; Dekel output upLSE:EVGEvgen Pharma Plc
10/11/202108:00RNS Non-RegulatoryEvgen Pharma PLC Publication of data on SFX-01 in glioblastomaLSE:EVGEvgen Pharma Plc
20/09/202115:50Alliance NewsAlliance NewsIN BRIEF: Evgen Pharma's SFX-01 effective on tumour cellsLSE:EVGEvgen Pharma Plc
20/09/202108:00RNS Non-RegulatoryEvgen Pharma PLC Publication of data in glioblastoma cellsLSE:EVGEvgen Pharma Plc
02/09/202112:56Alliance NewsAlliance NewsIN BRIEF: Evgen SFX-01 granted orphan drug designation by US FDALSE:EVGEvgen Pharma Plc
02/09/202112:46Dow Jones NewsEvgen Pharma Climbs on FDA Orphan-Drug Designation for Brain Tumor TreatmentLSE:EVGEvgen Pharma Plc
02/09/202112:01UK RegulatoryEvgen Pharma PLC Glioma Orphan Drug designation granted by FDALSE:EVGEvgen Pharma Plc
13/07/202118:02UK RegulatoryEvgen Pharma PLC Result of AGM and Business UpdateLSE:EVGEvgen Pharma Plc
13/07/202115:09Alliance NewsAlliance NewsIN BRIEF: Evgen Pharma files brain tumour treatment request with FDALSE:EVGEvgen Pharma Plc
13/07/202112:25Alliance NewsAlliance NewsIN BRIEF: Evgen Pharma encouraged by early data for SFX-01LSE:EVGEvgen Pharma Plc
13/07/202108:00RNS Non-RegulatoryEvgen Pharma PLC Early data for SFX-01 in leukaemia cell linesLSE:EVGEvgen Pharma Plc
13/07/202108:00UK RegulatoryEvgen Pharma PLC Glioma Orphan Drug application submitted to US FDALSE:EVGEvgen Pharma Plc
09/07/202112:51Alliance NewsAlliance NewsEvgen Pharma halts trial as SFX-01 drug fails to help Covid patientsLSE:EVGEvgen Pharma Plc
09/07/202108:00UK RegulatoryEvgen Pharma PLC Interim Safety and Futility Analysis - STAR trialLSE:EVGEvgen Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG

La tua Cronologia

LSE
0VH4
Shamaran Petroleum
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network